patient-specific embryonic stem cells derived human scnt blastocysts retracted article see vol pg
patient-specific immune-matched human embryonic stem cells hescs anticipated great biomedical importance studies disease development advance clinical deliberations regarding stem cell transplantation eleven hesc lines established somatic cell nuclear transfer scnt skin cells patients disease injury donated oocytes lines nuclear transfer nt-hescs grown human feeders nt donor genetically unrelated individuals established high rates regardless nt donor sex age nt-hescs pluripotent chromosomally normal matched nt patients dna major histocompatibility complex identity nt-hesc compared patients showed immunological compatibility important eventual transplantation generation nt-hescs evaluations genetic epigenetic stability can made additional work remains done regarding development reliable directed differentiation elimination remaining animal components clinical use cells can occur preclinical evidence required prove transplantation differentiated nt-hescs can safe effective tolerated
